Home Cart 0 Sign in  
X

[ CAS No. 942853-22-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 942853-22-7
Chemical Structure| 942853-22-7
Chemical Structure| 942853-22-7
Structure of 942853-22-7 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 942853-22-7 ]

Related Doc. of [ 942853-22-7 ]

Alternatived Products of [ 942853-22-7 ]
Product Citations

Product Details of [ 942853-22-7 ]

CAS No. :942853-22-7 MDL No. :MFCD08556202
Formula : C6H5F3N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :OJXAMYQOVDVCHO-UHFFFAOYSA-N
M.W : 194.11 Pubchem ID :16490806
Synonyms :

Calculated chemistry of [ 942853-22-7 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.33
Num. rotatable bonds : 3
Num. H-bond acceptors : 6.0
Num. H-bond donors : 1.0
Molar Refractivity : 35.45
TPSA : 55.12 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.67 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.76
Log Po/w (XLOGP3) : 1.14
Log Po/w (WLOGP) : 2.4
Log Po/w (MLOGP) : 0.5
Log Po/w (SILICOS-IT) : 0.69
Consensus Log Po/w : 1.1

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.85
Solubility : 2.75 mg/ml ; 0.0142 mol/l
Class : Very soluble
Log S (Ali) : -1.89
Solubility : 2.49 mg/ml ; 0.0128 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.08
Solubility : 16.2 mg/ml ; 0.0836 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.77

Safety of [ 942853-22-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 942853-22-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 942853-22-7 ]

[ 942853-22-7 ] Synthesis Path-Downstream   1~8

  • 1
  • [ 942853-22-7 ]
  • [ 1309889-07-3 ]
  • [ 1309952-08-6 ]
YieldReaction ConditionsOperation in experiment
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; triethylamine; In N,N-dimethyl-formamide; at 20.0℃; for 3h; The crude intermediate Da is dissolved in DMF (5 mL) along with TEA (0.18 mL, 1.25 mmol, 5 equiv), 1-(2,2,2-trifluoro-ethyl)-1 H-pyrazole-3-carboxylic acid R2f (58 mg, 0.30 mmol, 1.2 equiv) and TBTU (121 mg, 0.38 mmol, 1.5 equiv). Upon stirring at RT for 3 h, H20 and EtOAc are added. The layers are separated and the aqueous phase is extracted with EtOAc (2x). The organics are combined and dried by passing through an 1ST separator cartridge, and then concentrated. The mixture is purified by Combiflash (12 g column, eluent: Hex / EtOAc, 20% to 100% gradient). A second purification by Combiflash is performed (12 g column, eluent: Hex / EtOAc, 60% isocratic). The pure fractions are combined and concentrated. The product is then re-dissolved in acetonitrile and filtered through a Millex filter, frozen and lyophilized to provide compound 1012.UPLC-MS (electrospray): 874.4 (M+H), 872.5 (M-H)Retention time (min): 6.0 min1H NMR (400 MHz, DMSO-d6): delta 1 .05 (s, 1 H), 8.79 (s, 1 H), 7.97 (d, J = 7.0 Hz,1 H), 7.93 (d, J = 2.4 Hz, 1 H), 7.84 (d, J = 9.0 Hz, 1 H), 7.07 (d, J = 9.0 Hz, 1 H), 6.76 (d, J= 2.4 Hz, 1H), 6.36 (s, 1H), 5.65-5.58 (m, 1H), 5.49 (S, J= 6.0 Hz, 1H), 5.44 (bs, 1H), 5.23 (q, J= 9.0 Hz, 1H), 5.14 (dd, J= 9.4, 9.8 Hz, 1H), 4.62-4.59 (m, 1H), 4.53 (d, J= 11.6 Hz, 1H), 4.36 (dd, J= 7.0, 9.8 Hz, 1H), 4.00 (dd, J = 3.3, 11.6 Hz, 1H), 3.87 (s, 3H), 2.95-2.88 (m, 1H), 2.63-2.55 (m, 2H), 2.43 (s, 3H), 2.38-2.28 (m, 2H), 2.00-1.91 (m, 1 H), 1.83-1.73 (m, 1 H), 1.59-1.52 (m, 3H), 1.48-1.22 (m, 7H), 1.39 (d, J = 5.9 Hz, 3H), 1.38 (d, J = 5.9 Hz, 3H), 1.11-0.98 (m, 4H).
  • 2
  • [ 942853-22-7 ]
  • [ 1309889-11-9 ]
  • [ 1309952-22-4 ]
YieldReaction ConditionsOperation in experiment
Acid R2f (17.0 mg; 0.088 mmol, 1.2 equiv) is dissolved in DMF (1 mL) and TEA (40.7 mu; 0.292 mmol, 4.00 equiv) and TBTU (27.0 mg; 0.088 mmol, 1.20 equiv) are added and the mixture is stirred for 15 mins. The Boc de-protected macrocyclic amine hydrochloride Cc (50 mg, 0.075 mmol) is dissolved in DMF (1.0 mL) and added to the acid solution. The reaction is stirred at RT overnight. The resulting solution is filtered through a Millex filter and purified by prep HPLC (ammonium bicarbonate/MeOH) The pure fractions are combined, concentrated, frozen and lyophilized to provide compound 1026. FIA M.S.(electrospray) : 890.4 (M-H)- , 892.4 (M+H)+ Retention time (min): 6.0 min1H NMR (400 MHz,DMSO-d6): delta 10.81 (s, 1 H) , 8.88 (s, 1 H), 7.99 (d, 1 H, J = 6.3Hz), 7.95 (d, 1 H, J = 2.4 Hz), 7.80 (d, 1 H, J = 12.1 Hz), 7.24 (d, 1 H, J = 8.3Hz), 6.73 (d 1 H, J = 2.3 Hz), 6.46 (s, 1 H), 5.75-5.55 (m, 1 H), 5.50-5.45 (p, 1 H, J = 6.2 Hz), 5.45 (bs,1 H), 5.24-5.18 (m, 2H), 5.09-5.04 (m, 1 H), 4.61 (d, 1 H, J = 10.9Hz), 4.51 (m, 1 H), 4.38 (dd, 1 H, J = 7.0Hz, J = 9.4Hz), 3.95 (s, 3H), 2.67-2.59 (m, 2H), 2.34-2.29 (m, 2H), 2.03-1.91 (m, 1 H), 1.77-1.76 (m, 1 H), 1 .58-1.24(m, 21 H), 0.89-0.84 (m, 2H).
  • 3
  • [ 942853-22-7 ]
  • [ 1309888-83-2 ]
  • [ 1309952-01-9 ]
YieldReaction ConditionsOperation in experiment
Acid R2f (12 mg, 0.064 mmol, 1.3 equiv) is dissolved in DMF (0.5 mL), then TEA (34 mu, 0.25 mmol, 5.0 equiv) is added followed by TBTU (22 mg, 0.059 mmol, 1.2 equiv). The solution is stirred for 15 mins, after which the amine hydrochloride Ca is added in DMF (0.5 mL). The resulting solution is stirred at RT for 16 h. Water (2 mL) is added and the organic layer is extracted with EtOAc (3 x 5 mL). The solvent is evaporated and purification is performed by prep HPLC (MeCN:H20, 0.1 % TFA). The pure fractions are combined, concentrated, frozen and lyophilized to provide compound 1005. FIA M.S.(electrospray) : 888.5 (M+H)+ Retention time (min): 6.1 min1H NMR (400 MHz,DMSO-d6): delta 10.80 (s, 1 H) , 8.93 (s, 1 H), 7.95-7.90 (m, 2H), 7.84 (d, 1 H, J = 8.9 Hz), 7.07 (d, 1 H, J = 8.9 Hz), 6.75 (d, 1 H, J = 2.7 Hz), 6.37 (s, 1 H), 5.67-5.59 (m, 1 H), 5.55-5.44 (m, 2H), 5.27-5.18 (q, 2H, J = 9.2 Hz), 5.07 (dd, 1 H, J = 9.5, 9.0 Hz), 4.65-4.59 (m, 1 H) 4.53 (d, 1 H, J = 1 1.5 Hz), 4.43 (dd, 1 H, J = 9.6, 7.1 Hz), 4.03 (dd, 1 H, J = 1 1.8, 3.7 Hz), 3.88 (s, 3H), 2.66-2.57 (m, 1 H), 2.44 (s, 3H), 2.40-2.29 (m, 2H), 2.04-1.92 (m, 1 H), 1.89-1.78 (m, 1 H), 1.63-1.49, (m, 3H), 1.47- 1.36 (m, 14H), 1.34-1.20 (m, 4H), 0.93-0.84 (m, 2H).
  • 4
  • [ 942853-22-7 ]
  • [ 1309889-15-3 ]
  • [ 1309889-52-8 ]
YieldReaction ConditionsOperation in experiment
Compound 1029; Starting material Ai (45 mg, 0.056 mmol) is dissolved in 4 N HCI/dioxane and the reaction mixture is for 1 h at RT. The reaction mixture is concentrated in vacuo to give crude Ci. The acid R2i is dissolved in DMF (2.0 mL), DIPEA (0.059 mL, 0.338 mmol) and TBTU (21 .7 mg, 0.068 mmol) are added. The reaction mixture is stirred for 15 mins. The crude Ci is added and the reaction mixture is stirred at RT for 16 h. The reaction mixture is purified by prep HPLC to provide compound 1029. FIA M.S.(electrospray) : 874.4 (M+H)+ Retention time (min) = 6.0 min1H NMR (400 MHz,DMSO-d6): delta 10.83 (s, 1 H) , 8.92 (s, 1 H), 7.95 (b, 1 H), 7.93 (d, 1 H, J = 2.3 Hz), 7.86 (d, 1 H, J = 9.0 Hz), 7.08 (d, 1 H, J = 9.4 Hz), 6.74 (d, 1 H, J = 2.3 Hz), 6.40 (s, 1 H), 5.60 (b, 1 H), 5.44 (m, 1 H), 5.23 (q, 2H, J = 9.3 Hz), 5.09 (b, 1 H), 4.63 (b, 1 H), 4.47 (q, 2H, J = 6.9 Hz), 4.43 (b, 2H), 4.04 (b, 1 H), 3.87 (s, 3H), 2.67-2.65 (m, 1 H), 2.43 (s, 3H), 2.38-2.32 (m, 3H), 2.01 -1 .80 (m, 2H), 1 .58-1 .51 (m, 3H), 1 .44-1 .23 (m, 1 1 H), 1 .39 (t, 3H, J = 7.0 Hz), 0.85 (b, 2H).
  • 5
  • [ 942853-22-7 ]
  • [ 1309889-19-7 ]
  • [ 1309889-46-0 ]
YieldReaction ConditionsOperation in experiment
Intermediate Ck is prepared from Ak by treatment with 4 N HCI/dioxane for 1 h followed by concentration in vacuo. Acid R2i (12.2 mg, 0.063 mmol) is dissolved in DMF (1 ml_), then TEA (29 muIota_, 0.210 mmol) is added followed by TBTU (19.4 mg, 0.060 mmol). The solution is stirred for 15 mins, after which the amine hydrochloride Ck (40 mg, 0.053 mmol) is added in DMF (1 mL). The solution is stirred at RT for 16 h. AcOH is added and the resulting solution is filtered through a Millex filter and purified by prep HPLC (Sunfire column, 0.1% TFA). The pure fractions are combined, frozen and lyophilized to provide compound 1023.FIA M.S.(electrospray) : 900.4 (M+H)+ Retention time (min) = 6.4 min1H NMR (400 MHz,DMSO-d6): delta 10.82 (s, 1H) , 8.94 (s, 1H), 7.96 (d, 1H, J = 7.1 Hz), 7.93 (d, 1H, J = 2.3 Hz), 7.84 (d, 1H, J = 9 Hz), 7.07 (d, 1H, J = 9.4 Hz), 6.74 (d, 1 H, J = 2.3 Hz), 6.40 (s, 1 H), 5.65-5.58 (m 1 H), 5.48-5.43 (m, 1 H), 5.32 (qn, 1 H J = 7.8 Hz), 5.22 (q, 2H, J = 9 Hz), 5.06 (dd, 1H, J = 9.8, 9.4 Hz), 4.63-4.57 (m, 1H), 4.54 (d, 1H, J= 11.8), 4.41 (dd, 1H, J= 7.4, 7.0 Hz), 4.04-4.00 (m, 1H), 3.87 (s, 3H), 2.64-2.58 (m, 2H), 2.43 (s, 3H), 2.38-2.31 (m, 3H), 2.15-2.08 (m, 2H), 2.01-1.98 (m, 1H), 1.85-1.67 (m, 3H), 1.59-1.23 (m, 15H), 0.90-0.86 (m, 2H).
  • 6
  • [ 942853-22-7 ]
  • [ 1366663-05-9 ]
  • [ 1366660-48-1 ]
  • 7
  • [ 1245772-13-7 ]
  • [ 942853-22-7 ]
YieldReaction ConditionsOperation in experiment
69% Example 256: 2-N-Methyl-2-N-phenyl-6-{5-[1-(2,2,2-trifluoroethyl)-1 H-pyrazol-3-yl]-1 ,2,4- oxadiazol-3-yl}-1 ,3,5-triazine-2,4-diamine (Method 12)Methyl 1-(2,2,2-trifluoroethyl)-1 H-pyrazole-3-carboxylate (Intermediate 204, 0.312 g, 1.5 mmol) was dissolved in a mixture of THF (2 mL), MeOH (2 mL) and water (1 mL); lithium hydroxide (0.188 g, 4.5 mmol) was added and the mixture was stirred at roomtemperature for 16 h. The mixture was concentrated, the residue dissolved in water (1 mL) and the mixture was neutralised. This was extracted with EtOAc (2 x 10 mL), the organic extracts were dried over sodium sulfate and concentrated under vacuum. The crude material was washed with pentane (2 x 10 mL) to afford 1-(2,2,2-trifluoroethyl)-1 H- pyrazole-3-carboxylic acid (0.200 g, 69%). 2-N-methyl-2-N-phenyl-6-{5-[1-(2,2,2- trifluoroethyl)-1 H-pyrazol-3-yl]-1 ,2,4-oxadiazol-3-yl}-1 ,3,5-triazine-2,4-diamine was then prepared from 1-(2,2,2-trifluoroethyl)-1 H-pyrazole-3-carboxylic acid (0.159 g, 0.820 mmol) and 4-amino-N-hydroxy-6-[methyl(phenyl)amino]-1 ,3,5-triazine-2- carboximidamide (prepared in an analogous manner to Intermediate 1 , 0.125 g, 0.483 mmol) according to the method described for Example 251 to afford the title compound (0.110 g, 55%).
  • 8
  • [ 942853-22-7 ]
  • C35H47N5O8S*ClH [ No CAS ]
  • C41H50F3N7O9S [ No CAS ]
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 942853-22-7 ]

Fluorinated Building Blocks

Chemical Structure| 1006486-39-0

[ 1006486-39-0 ]

1-(2,2-Difluoroethyl)-1H-pyrazole-3-carboxylic acid

Similarity: 0.97

Chemical Structure| 1198437-47-6

[ 1198437-47-6 ]

1-(2-Fluoroethyl)-1H-pyrazole-3-carboxylic acid

Similarity: 0.94

Chemical Structure| 1006486-45-8

[ 1006486-45-8 ]

5-Methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazole-3-carboxylic acid

Similarity: 0.93

Chemical Structure| 1245772-13-7

[ 1245772-13-7 ]

Methyl 1-(2,2,2-trifluoroethyl)-1H-pyrazole-3-carboxylate

Similarity: 0.92

Chemical Structure| 89239-83-8

[ 89239-83-8 ]

3-Methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazole-5-carboxylic acid

Similarity: 0.90

Carboxylic Acids

Chemical Structure| 1006486-39-0

[ 1006486-39-0 ]

1-(2,2-Difluoroethyl)-1H-pyrazole-3-carboxylic acid

Similarity: 0.97

Chemical Structure| 1198437-47-6

[ 1198437-47-6 ]

1-(2-Fluoroethyl)-1H-pyrazole-3-carboxylic acid

Similarity: 0.94

Chemical Structure| 1006486-45-8

[ 1006486-45-8 ]

5-Methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazole-3-carboxylic acid

Similarity: 0.93

Chemical Structure| 89239-83-8

[ 89239-83-8 ]

3-Methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazole-5-carboxylic acid

Similarity: 0.90

Chemical Structure| 1006340-71-1

[ 1006340-71-1 ]

1-(2,2,2-Trifluoroethyl)-1H-pyrazole-5-carboxylic acid

Similarity: 0.90

Trifluoromethyls

Chemical Structure| 1006486-45-8

[ 1006486-45-8 ]

5-Methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazole-3-carboxylic acid

Similarity: 0.93

Chemical Structure| 1245772-13-7

[ 1245772-13-7 ]

Methyl 1-(2,2,2-trifluoroethyl)-1H-pyrazole-3-carboxylate

Similarity: 0.92

Chemical Structure| 89239-83-8

[ 89239-83-8 ]

3-Methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazole-5-carboxylic acid

Similarity: 0.90

Chemical Structure| 1006340-71-1

[ 1006340-71-1 ]

1-(2,2,2-Trifluoroethyl)-1H-pyrazole-5-carboxylic acid

Similarity: 0.90

Chemical Structure| 1245772-76-2

[ 1245772-76-2 ]

1-(3,3,3-Trifluoropropyl)-1H-pyrazole-3-carboxylic acid

Similarity: 0.90

Related Parent Nucleus of
[ 942853-22-7 ]

Pyrazoles

Chemical Structure| 1006486-39-0

[ 1006486-39-0 ]

1-(2,2-Difluoroethyl)-1H-pyrazole-3-carboxylic acid

Similarity: 0.97

Chemical Structure| 1198437-47-6

[ 1198437-47-6 ]

1-(2-Fluoroethyl)-1H-pyrazole-3-carboxylic acid

Similarity: 0.94

Chemical Structure| 1006486-45-8

[ 1006486-45-8 ]

5-Methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazole-3-carboxylic acid

Similarity: 0.93

Chemical Structure| 1245772-13-7

[ 1245772-13-7 ]

Methyl 1-(2,2,2-trifluoroethyl)-1H-pyrazole-3-carboxylate

Similarity: 0.92

Chemical Structure| 89239-83-8

[ 89239-83-8 ]

3-Methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazole-5-carboxylic acid

Similarity: 0.90

; ;